✦ LIBER ✦

Monotherapy with hMG-CoA reductase inhibitors and secondary prevention in coronary artery disease

✍ Scribed by Charles E. Rackley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic Change of HMG-CoA Reductase

✍ Daniel E. Hilleman; Richard L. Wurdeman; Thomas L. Lenz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Early introduction of HMG-CoA reductase

✍ T Kato; T Tokoro; Y Namii; T Kobayashi; S Hayashi; I Yokoyama; S Morimoto; M Cha 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 60 KB

HMG CoA reductase inhibitors are related

✍ Mikko J Järvisalo; Jyri O Toikka; Tommi Vasankari; Jorma Mikkola; Jorma S.A Viik 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

PCV22: COST-EFFECTIVENESS OF HMG-CoA RED

✍ LB Lazebnik; MJ Kadiskaya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Monotherapy with HMG-CoA reductase inhib

✍ J.W.A. Smit; J. Contermans; D.W. Erkelens; P. Ba¨r 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 159 KB

The Rationale for Using HMG-CoA Reductas

✍ G. Erez; E. Leitersdorf 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 168 KB